Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) reported Q3 EPS of ($0.32), in-line with the analyst estimate of ($0.32).

For earnings history and earnings-related data on Eledon Pharmaceuticals, Inc. (ELDN) click here.